MicroRNA-143 inhibits proliferation and migration of prostate cancer cells

Elshan Bajhan1, Behzad Mansoori2, Ali Mohammadi2

  • 1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Insights

MicroRNA-143 replacement in prostate cancer (PC) cells reduced cell growth and migration. This suggests miRNA-143 is a potential target for developing new PC molecular therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer (PC) is a leading male malignancy.
  • Investigating the role of microRNA-143 (miRNA-143) in PC progression.
  • Utilizing a vector-based approach to restore miRNA-143 levels in PC cells.

Purpose of the Study:

  • To evaluate the effect of miRNA-143 restoration on prostate cancer cell behavior.
  • To assess the impact of miRNA-143 on cell proliferation, migration, and apoptosis.
  • To explore miRNA-143 as a potential therapeutic target for PC.

Main Methods:

  • Transfection of a miRNA-143 vector into PC3 cells.
  • Quantitative reverse transcription PCR (qRT-PCR) to measure gene expression.
  • MTT, scratch wound-healing, and DAPI staining assays to assess cell proliferation, migration, and apoptosis.

Main Results:

  • Successful restoration of miRNA-143 expression in transfected PC3 cells.
  • Significant reduction in cell proliferation and migration observed in miRNA-143 transfected cells compared to controls.
  • qRT-PCR confirmed altered expression of cancer-associated genes following miRNA-143 transfection.

Conclusions:

  • miRNA-143 plays a crucial role in regulating prostate cancer cell growth and metastasis.
  • Restoring miRNA-143 function can inhibit PC cell proliferation and migration.
  • miRNA-143 represents a promising candidate for future molecular therapies targeting prostate cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K